» Articles » PMID: 24522477

Novel Metabolic Roles of L-arginine in Body Energy Metabolism and Possible Clinical Applications

Overview
Date 2014 Feb 14
PMID 24522477
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Although the body can synthesize L-arginine, exogenous supplementation may be sometimes necessary, especially in particular conditions which results in depleted endogenous source. Among diseases and states when exogenous supplementation may be necessary are: burns, severe wounds, infections, insufficient circulation, intensive physical activity or sterility. In recent time, the attention was paid to the use of L-arginine supplementation by athletes during intensive sport activity, to enhance tissue growth and general performance, to potentiate the ergogenic potential and muscle tolerance to high intensive work and gas exchange threshold, to decrease ammonia liberation and recovery performance period and to improve wound healing. High-intensity exercise produces transient hyperammoniemia, presumably due to AMP catabolism. Catabolic pathways of AMP may involve its deamination or dephosphorylation, mainly in order to compensate fall in adenylate enrgy charge (AEC), due to AMP rise. The enzymes of purine metabolism have been documented to be particularly sensitive to the effect of dietary L-arginine supplementation. L-arginine supplementation leads to redirection of AMP deamination on account of increased AMP dephosphorylation and subsequent adenosine production and may increase ATP regeneration via activation of AMP kinase (AMPK) pathway. The central role of AMPK in regulating cellular ATP regeneration, makes this enzyme as a central control point in energy homeostasis. The effects of L-arginine supplementation on energy expenditure were successful independently of age or previous disease, in young sport active, elderly, older population and patients with angina pectoris.

Citing Articles

L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy.

Fiordelisi A, Cerasuolo F, Avvisato R, Buonaiuto A, Maisto M, Bianco A Cardiovasc Diabetol. 2024; 23(1):450.

PMID: 39707340 PMC: 11662564. DOI: 10.1186/s12933-024-02490-x.


Evaluation of a Cosmetic Formulation Containing Arginine Glutamate in Patients with Burn Scars: A Pilot Study.

Kim H, Kwak I, Kim M, Um J, Lee S, Chung B Pharmaceutics. 2024; 16(10).

PMID: 39458612 PMC: 11510376. DOI: 10.3390/pharmaceutics16101283.


Tailored biomedical materials for wound healing.

Liu W, Zu L, Wang S, Li J, Fei X, Geng M Burns Trauma. 2023; 11:tkad040.

PMID: 37899884 PMC: 10605015. DOI: 10.1093/burnst/tkad040.


Nitric Oxide as a Determinant of Human Longevity and Health Span.

Poeggeler B, Singh S, Sambamurti K, Pappolla M Int J Mol Sci. 2023; 24(19).

PMID: 37833980 PMC: 10572643. DOI: 10.3390/ijms241914533.


Role of arginine supplementation on muscular metabolism and flesh quality of Pacific white shrimp () reared in freshwater.

Li M, Wen H, Huang F, Wu M, Yu L, Jiang M Front Nutr. 2022; 9:980188.

PMID: 36118779 PMC: 9473507. DOI: 10.3389/fnut.2022.980188.


References
1.
Ceremuzynski L, Chamiec T . Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol. 1997; 80(3):331-3. DOI: 10.1016/s0002-9149(97)00354-8. View

2.
Goncalves L, Bessa A, Freitas-Dias R, Luzes R, Werneck-de-Castro J, Bassini A . A sportomics strategy to analyze the ability of arginine to modulate both ammonia and lymphocyte levels in blood after high-intensity exercise. J Int Soc Sports Nutr. 2012; 9(1):30. PMC: 3502551. DOI: 10.1186/1550-2783-9-30. View

3.
Jabecka A, Ast J, Bogdaski P, Drozdowski M, Pawlak-Lemaska K, Cielewicz A . Oral L-arginine supplementation in patients with mild arterial hypertension and its effect on plasma level of asymmetric dimethylarginine, L-citruline, L-arginine and antioxidant status. Eur Rev Med Pharmacol Sci. 2012; 16(12):1665-74. View

4.
Tan B, Li X, Yin Y, Wu Z, Liu C, Tekwe C . Regulatory roles for L-arginine in reducing white adipose tissue. Front Biosci (Landmark Ed). 2012; 17(6):2237-46. PMC: 3422877. DOI: 10.2741/4047. View

5.
Boger R, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B . LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res. 2000; 87(2):99-105. DOI: 10.1161/01.res.87.2.99. View